Amyris

Amyris, Inc. is a biotechnology company headquartered in Emeryville, California, specializing in the development of microbial strains to produce sustainable ingredients from renewable plant-sourced sugars. Founded in 2003, Amyris utilizes its industrial synthetic biology platform to engineer and manufacture a wide range of products, including ingredients for cosmetics, flavors, fragrances, healthcare, and fuels. The company’s innovative technology enables the conversion of plant sugars into high-value hydrocarbon molecules, providing no-compromise alternatives to petroleum-based products. Amyris operates under several trademarks, including Biofene and Biossance, and collaborates with organizations such as the Infectious Disease Research Institute to advance health-related initiatives, including vaccine development. The company generates revenue from product sales, intellectual property licensing, and collaborative research efforts, with a significant portion of its business occurring in the United States.